The son of a pharmaceutical-company director was convicted in New York of leaking company secrets to a close friend who prosecutors say was part of a global
Telemaque Lavidas, 39, was the first U.S. defendant tried in connection with an insider scheme that generated tens of millions of dollars on illegal tips about drug companies from investment bankers and corporate insiders. Though Lavidas played a small role in the plot, his trial in Manhattan shed light on how a corrupt Swiss trader and others exploited contacts on three continents for market-moving information.
Lavidas was found guilty Wednesday ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.